Hemophagocytic Syndrome in Epstein-Barr Virus-Associated T-Lymphoproliferative Disorders: Disease Spectrum, Pathogenesis, and Management

References

• Scott R. B., Robb-Smith A. H. T. Histiocytic medullary reticulosis. Lancet 1939; 2: 194–198
   Google Scholar
• Rappaport H. Tumors of the hematopoietic system. In Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, D. C. 1966; 49–63
   Google Scholar
• Warnke R. A., Kim H., Dorfman R. F. Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopathology; Study of 29 cases. Cancer 1975; 35: 215–230
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsu Y. H., Lin M. T., Cheng A. L., Wang C. W., Weiss L. M. Epstein-Barr virus-containing T cell lymphoma presents with hemophagocytic syndrome mimicking malignant his-tiocytosis. Cancer 1993; 72: 2019–2027
   PubMed Web of Science ®Google Scholar
• Risdall R. J., McKenna R. W., Nesbit M. E., et al. Virus-associated hemophagocytic, syndrome-A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993–1002
   PubMed Web of Science ®Google Scholar
• Ladisch S., Holiman B., Poplack D. G., et al. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet 1978; 1: 581–583
   PubMed Web of Science ®Google Scholar
• Henter J. I., Elinder G., Ost A. The FHL study group of the histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin. Oncol. 1991a; 18: 29–33
   PubMed Web of Science ®Google Scholar
• Jaffe E. S., Costa J., Fauci A. S., Cossman J., Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am. J. Med. 1993; 75: 741–749
   Web of Science ®Google Scholar
• Wilson M. S., Weiss L. M., Gatter K. C., Mason D. Y., Dorfman R. F., Warnke R. A. Malignant histiocytosis: a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping. Cancer 1990; 66: 530–536
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsieh H. C., Lee C. Y. Histiocytic medullary reticulosis: a lethal form of primary EBV infection in young children in Taiwan. Lancet 1989; 1: 389
   PubMed Web of Science ®Google Scholar
• Farquhar J. W., Claireaux A. F. Familial hemophagocytic reticulosis. Arch. Dis. Child. 1952; 27: 519–525
   PubMed Web of Science ®Google Scholar
• Liang D. C., Chu M. L., Shih C. C. Reactive histiocytosis in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma. Cancer 1986; 58: 1289–1294
   PubMed Web of Science ®Google Scholar
• Ng C. S., Chan J. K. C., Cheng P. N. M., et al. Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer 1986; 58: 67–71
   PubMed Web of Science ®Google Scholar
• Myers T. J., Kessimian N., Schwartz S. Mediastinal germ cell tumor associated with the hemophagocytic syndrome. Ann. Intern. Med. 1988; 109: 504–505
   PubMed Web of Science ®Google Scholar
• Risdall R. J., Brunning R. D., Hernandez J. I., et al. Bacteria-associated hymophagocytic syndrome. Cancer 1984; 54: 2968–72
   PubMed Web of Science ®Google Scholar
• Weintraub M., Siegman-Igra Y., Josiphov J., et al. Histiocytic hymophagocytosis in miliary tuberculosis. Arch. Intern. Med. 1984; 144: 2055–7
   PubMed Web of Science ®Google Scholar
• Mroczek E. C., Weisenburger D. D., Grierson H. L., Markin R., Purtilo D. T. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch. Pathol. Lab. Med. 1987; 111: 530–535
   PubMed Web of Science ®Google Scholar
• Craig F. E., Clare C. N., Sklar J. L., Banks P. M. T cell lymphoma and the virus-associated hemophagocytic syndrome. Am. J. Clin. Pathol. 1992; 97: 189–194
   PubMed Web of Science ®Google Scholar
• Falini B., Pileri S., Solas I. D., et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990; 75: 434–44
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsieh H. C., Lin K. H., et al. Aggressive peripheral T cell lymphoma containing Epstein-Bar virus DNA: a clinicopathological and molecular analysis. Blood 1991; 77: 799–808
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsieh H. J. Clinicopathological spectrum of Epstein-Barr virus associated T-cell malignancy. Leuk. Lymph. 1992; 17: 47–53
   Web of Science ®Google Scholar
• Weiss L. M., Faffe E., Liu X. F., Chen Y. Y., Shibata D., Medeiros L. J. Detection and localization of Epstein-Barr virus genomes in angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992; 79: 1789–1795
   PubMed Web of Science ®Google Scholar
• Korbjuhn P., Anagnostopoulos I., Hummel M., Tiemann M., Dallenbach F., Parwaresch M. R., Stein H. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood 1993; 82: 217–223
   PubMed Web of Science ®Google Scholar
• Harrington D. S., Weisenburger D. D., Purtilo D. T. Epstein-Barr virus-associated lymphoproliferative lesions. Clinics in Laboratory Med. 1988; 8: 97–118
   PubMed Web of Science ®Google Scholar
• Ho F. C. S., Srivastava G., Loke S. L., Fu K. H., Leung B. P. Y., Liang R., Choy D. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol. Oncol. 1990; 8: 271–281
   PubMed Web of Science ®Google Scholar
• Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. Epstein-Barr virus in T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; i: 128–129
   Web of Science ®Google Scholar
• Yao M., Cheng A. L., Su I. J., et al. Clinicopathologic spectrum of hemophagocytic syndrome in Epstein-Barr virus-associated peripheral T cell lymphoma. Br. J. Hematol. 1994; 87: 535–543
   PubMed Web of Science ®Google Scholar
• Chen R. L., Su I. J., Lin K. S., Lee S. H., Lin D. T., Chuu W. M., Link K. S., Hung L. M., Lee C. Y. Fulminant childhood hemophagocytic medullary reticulosis. Am. J. Clin. Pathol. 1991; 96: 171–176
   PubMed Web of Science ®Google Scholar
• Haung L. M., Lee C. Y., Lin K. H. Human herpesvirus type-6-associated with fatal haemophagocytic syndrome. Lancet 1990; 336: 60–61
   PubMed Web of Science ®Google Scholar
• Su I. J., Chen R. L., Lin D. T., Lin K. S., Chen C. C. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am. J. Pathol. 1994; 144: 1219–1225
   PubMed Web of Science ®Google Scholar
• Gaffey M. J., Frierson H. F., Medeiros L J., Weiss L. M. The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytic syndrome and secondary (lymphoma-related) hemophagocytosis: an in situ hybridization study. Hum. Pathol. 1993; 24: 657–667
   PubMed Web of Science ®Google Scholar
• Simrell C. R., Margolick J. B., Crabtree G. R., et al. Lymphokine-induced phagocytosis in angiocentric immunoproliferativeerative lesions (AIL) and malignant lymphoma arising in AIL. Blood 1985; 65: 1469–1476
   PubMed Web of Science ®Google Scholar
• Ohga S, Matsuzaki A., Nishizaki M., Nagashima T., Kai T., Suda M., Ueda K. Inflammatory cytkines in virus-associated hemophagocytic syndrome: interferon gamma as a sensitive indicator of disease activity. Am. J. Pediat. Hematol. Oncol. 1993; 15: 291–298
   PubMedGoogle Scholar
• Henter J. I., Elinder G., Soder O., Hansson M., Anderson B., Anderson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991b; 78: 2918–2922
   PubMed Web of Science ®Google Scholar
• Temeles D. S., McGrath H. E., Kitter E. L. W., Shadduck R. K., Kister V. K., Crittenden R. B., Turner B. L., Quesenberry P. J. Cytokine expression from bone marrow derived macrophages. Exper. Hematol. 1993; 21: 388–393
   PubMed Web of Science ®Google Scholar
• Foss H. D., Herbst H., Hummel M., et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood 1994; 83: 707–712
   PubMed Web of Science ®Google Scholar
• Hallet M. M., Praloran V., Vie H., Peyrat M. A., Wong G., Witek-Gianotti J., Soulillou J. P., Moreau J. F. Macrophage colony-stimulating factor (CSF-1) gene expression in human T-lymphocyte clones. Blood 1991; 77: 780–786
   PubMed Web of Science ®Google Scholar
• Murray H. W., Scavuzzo D., Jacobs J. L. In vitro and in vivo activation of human mononuclear phagocytes by interferon gamma: studies with normal and AIDS monocytes. J. Immunol. 1987; 138: 2457–2462
   PubMed Web of Science ®Google Scholar
• Khwaja A., Johnson R., Addison I. E., Yong K., Ruthven K., Abramson S., Linch D. C. In vivo effects of macrophage colony-stimulating factor on human monocyte function. Br. J. Haematol. 1991; 77: 25–31
   PubMed Web of Science ®Google Scholar
• Navarro S., Debili N., Bemaudin J. F., Vainchenker W., Doly J. Regulation of the expression of IL-6 inhuman monocytes. J. Immunol. 1989; 142: 4339–4345
   PubMed Web of Science ®Google Scholar
• Sandvig S., Laskay T., Andersson J., De Ley M., Andersson U. Gamma-interferon is produced by CD3+ and CD3-lymphocytes. Immunological Rev. 1987; 97: 51–62
   PubMed Web of Science ®Google Scholar
• Stanley E. R., Heard P. M. Factors regulating macrophage production and growth: purification and some properties of the colony-stimulating factor from medium conditioned by mouse L cell. J. Biol. Chem. 1977; 252: 4350–4312
   Google Scholar
• Warren M. K., Ralph P. Macrophage growth factor CSF-I stimulates human monocyte production of interferon, tumor necrosis factor, and colony-stimulating activity. J. Immunol. 1986; 13: 2281–2285
   Google Scholar
• Feingold K., Soued M., Staprans I., Gavin L. A., Donahue M. E., Huang B. J., Moser A. H., Gulli R., Grunfeld C. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat: evidence that inhibition of adipose tissue lipoprotein li-past: activity is not required for TNF-induced hyperlipidemia. J. Clin. Invest. 1980; 83: 1116–1121
   Web of Science ®Google Scholar
• Takamatsu Y., Akashi K., Harada M., Teshima T., Inaba S., Shimoda K., Eto T., Shibuya T., Okamura S., Niho Y. Cytokine production by peripheral blood monocytes and T-cells during haematopoietic recovery after intensive chemotherapy. Er. J. Haemutol. 1993; 83: 21–27
   PubMed Web of Science ®Google Scholar
• Simrell C. R., Crabtree G. R., Cossman J., et al. Stimulation of phagocytosis by a T-cell lymphoma derived lymphokine. Academic Press, New York 1982; Vol. 24: 247–252, Vitetta E: B and T Cell Tumors. UCLA Symposia in Msslecular and Cellular Biology
   Google Scholar
• Kanavaros P., Lescs M. C., Briere J., et al. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Zhou X. G., Hamilton-Duteit S. J., Yan Q. H., Pallesen G. High frequency of Epstein-Barr virus association in Chinese peripheral T-cell lymphoma. Histopathol. 1994; 24: 115–122
   PubMed Web of Science ®Google Scholar
• Cheng A. L., Su I. J., Chen Y. C., Uen W. C., Wang C. W. Characteristic clinicopathologic features of EBV-associated peripheral T-cell lymphoma. Cancer 1903; 72: 909–916
   Web of Science ®Google Scholar
• Akashi K., Hayashi S., Gondo H., et al. Involvement of interferon-gamma and macrophage-stimulating factor in pathogenesis of hemophagocytic lymphohistiocytosis in adults. Br. J. Hematol. 1994; 87: 243–250
   PubMed Web of Science ®Google Scholar
• Mizuhara H., O'Neill E., Seki N., et al. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by IL-6. J. Exp. Med. 1994; 179: 1529–1537
   PubMed Web of Science ®Google Scholar
• Henter J. I. Familial Hemophagocytic Lymphohistiocytosis. A Clinical, Metabolic and Immunological Study of a Lymphohistiocytic Inflammatory Disorder. Kongl Carolinska Medico Chirurgiska Institutet, StockholmSweden 1990; 16–64
   Google Scholar
• Brown R. E., Bowman W. P., d'Cruz C. A., et al. Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP-16 and indomethacin. Cancer 1991; 60: 2388–2393
   Web of Science ®Google Scholar
• Ambruso D. R., Hays T., Zwartjes W. J., Tubergen D. G., Favara B. E. Successful treatment of lymphohistiocytosis with epipidophyllotoxin VP-16–213. Cancer 1980; 45: 2516–2520
   PubMed Web of Science ®Google Scholar
• Nydegger U. E. Intravenous immunoglobulin in combination with other prophylactic and therapeutic measures. Transfusion 1992; 32: 72–82
   PubMed Web of Science ®Google Scholar
• Oyama Y., Amano T., Hirakawa S., Hironaka K., Suzuki S., Ota Z. Haemophagocytic syndrome treated with cyclosporin A: a T-cell disorder?. Brit. J. Haematol. 1989; 73: 276–277
   PubMed Web of Science ®Google Scholar
• Goulder P., Seward D., Hatton C. Intravenous immunoglobulin in virus-associated hemophagocytic syndrome. Arch. Dis. Child. 1990; 65: 1275–1277
   PubMed Web of Science ®Google Scholar
• Chen R. L., Lin K. H., Lin D. T., et al. Immunomodulation treatment for childhood virus-associated hemophagocytic lymphohistiocytosis. Br. J. Hematol., (in press)
   Web of Science ®Google Scholar